Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression.
Yip-Schneider MT, Lin A, Barnard D, Sweeney CJ, Marshall MS. Yip-Schneider MT, et al. Int J Oncol. 1999 Aug;15(2):271-9. doi: 10.3892/ijo.15.2.271. Int J Oncol. 1999. PMID: 10402237
Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers.
Yang Y, Liu H, Li Z, Zhao Z, Yip-Schneider M, Fan Q, Schmidt CM, Chiorean EG, Xie J, Cheng L, Chen JH, Zhang JT. Yang Y, et al. Int J Biochem Mol Biol. 2011 Jan 1;2(1):89-98. Int J Biochem Mol Biol. 2011. PMID: 21331354 Free PMC article.
Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells.
Yip-Schneider MT, Sweeney CJ, Jung SH, Crowell PL, Marshall MS. Yip-Schneider MT, et al. J Pharmacol Exp Ther. 2001 Sep;298(3):976-85. J Pharmacol Exp Ther. 2001. PMID: 11504793
Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2.
Yip-Schneider MT, Lin A, Marshall MS. Yip-Schneider MT, et al. Biochem Biophys Res Commun. 2001 Feb 2;280(4):992-7. doi: 10.1006/bbrc.2001.4243. Biochem Biophys Res Commun. 2001. PMID: 11162624
Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association.
Yip-Schneider MT, Miao W, Lin A, Barnard DS, Tzivion G, Marshall MS. Yip-Schneider MT, et al. Biochem J. 2000 Oct 1;351(Pt 1):151-9. doi: 10.1042/0264-6021:3510151. Biochem J. 2000. PMID: 10998357 Free PMC article.
Cyclooxygenase-2 expression in human pancreatic adenocarcinomas.
Yip-Schneider MT, Barnard DS, Billings SD, Cheng L, Heilman DK, Lin A, Marshall SJ, Crowell PL, Marshall MS, Sweeney CJ. Yip-Schneider MT, et al. Carcinogenesis. 2000 Feb;21(2):139-46. doi: 10.1093/carcin/21.2.139. Carcinogenesis. 2000. PMID: 10657949
Transcriptional induction of pim-1 protein kinase gene expression by interferon gamma and posttranscriptional effects on costimulation with steel factor.
Yip-Schneider MT, Horie M, Broxmeyer HE. Yip-Schneider MT, et al. Blood. 1995 Jun 15;85(12):3494-502. Blood. 1995. PMID: 7540064
Characterization of interleukin-7-induced changes in tyrosine phosphorylation and c-myc gene expression in normal human T cells.
Yip-Schneider MT, Horie M, Broxmeyer HE. Yip-Schneider MT, et al. Exp Hematol. 1993 Dec;21(13):1648-56. Exp Hematol. 1993. PMID: 7694866
Commentary: a rapid proliferation assay for unknown co-stimulating factors in cord blood plasma possibly involved in enhancement of in vitro expansion and replating capacity of human hematopoietic stem/progenitor cells.
Broxmeyer HE, Benninger L, Yip-Schneider M, Braun SE. Broxmeyer HE, et al. Blood Cells. 1994;20(2-3):492-7. Blood Cells. 1994. PMID: 7749116 No abstract available.
Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions.
Fujikura K, Hosoda W, Felsenstein M, Song Q, Reiter JG, Zheng L, Beleva Guthrie V, Rincon N, Dal Molin M, Dudley J, Cohen JD, Wang P, Fischer CG, Braxton AM, Noë M, Jongepier M, Fernández-Del Castillo C, Mino-Kenudson M, Schmidt CM, Yip-Schneider MT, Lawlor RT, Salvia R, Roberts NJ, Thompson ED, Karchin R, Lennon AM, Jiao Y, Wood LD. Fujikura K, et al. Among authors: yip schneider mt. Gut. 2020 Oct 7:gutjnl-2020-321217. doi: 10.1136/gutjnl-2020-321217. Online ahead of print. Gut. 2020. PMID: 33028669
55 results
Jump to page